Akèy › Gliyòm
Etid klinik pou Gliyòm ap rekrite nan Etazini
118 etid pou Gliyòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY25 etid
- Houston, TX23 etid
- Boston, MA20 etid
- Washington, DC19 etid
- Philadelphia, PA16 etid
- Miami, FL15 etid
- Columbus, OH15 etid
- San Francisco, CA14 etid
- Chicago, IL13 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- St. Louis, MO10 etid
- Aurora, CO10 etid
- Los Angeles, CA10 etid
- Cincinnati, OH9 etid
- Rochester, MN9 etid
- Edison, NJ8 etid
- Queens, NY7 etid
- Atlanta, GA7 etid
- Nashville, TN6 etid
- Dallas, TX6 etid
- Jacksonville, FL6 etid
- San Diego, CA6 etid
- Birmingham, AL6 etid
- Baltimore, MD6 etid
- Omaha, NE6 etid
- Orange, CA6 etid
- New Rochelle, NY5 etid
- San Antonio, TX5 etid
- Ann Arbor, MI5 etid
- Cleveland, OH5 etid
- Arlington, VA4 etid
- Tampa, FL4 etid
- Pittsburgh, PA4 etid
- Indianapolis, IN4 etid
- Staten Island, NY4 etid
- Greenburgh, NY4 etid
- East Norwalk, CT4 etid
- Salt Lake City, UT4 etid
- Phoenix, AZ4 etid
Pa eta
- Alabama6 etid
- Arizona8 etid
- Colorado11 etid
- Connecticut6 etid
- Distrik Columbia14 etid
- Florid23 etid
- Georgia7 etid
- Illinois13 etid
- Indiana4 etid
- Iowa3 etid
- Kalifòni25 etid
- Maryland11 etid
- Massachusetts20 etid
- Michigan8 etid
- Minnesota13 etid
- Missouri11 etid
- Nebraska6 etid
- New Jersey10 etid
- New York28 etid
- North Carolina16 etid
- Ohio18 etid
- Pennsylvania19 etid
- Tennessee8 etid
- Texas26 etid
- Utah4 etid
- Virginia5 etid
- Washington11 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05030298A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Ap rekriteFaz 1/2
12 Months – 21 Years · Tout sèks · Mizajou Sep 30, 2026 · NCT05099003Language Network Prehab Via fMRI Neurofeedback
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07488780Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03896568Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Ap rekriteFaz 1 bonè
Laj 1 a 21 · Tout sèks · Mizajou Sep 22, 2026 · NCT05555550Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT04977375ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Ap rekriteFaz 2
12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Ap rekriteFaz 1
Laj 5 a 18 · Tout sèks · Mizajou Sep 15, 2026 · NCT06357377Development of MRF for Characterization of Brain Tumors After Radiotherapy
Ap rekriteVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT06101069MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04373720Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04771806A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Ap rekriteFaz 1
Laj 3 a 25 · Tout sèks · Mizajou Sep 9, 2026 · NCT07664176Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Ap rekriteFaz 1
36 Months · Tout sèks · Mizajou Sep 9, 2026 · NCT07076498Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388A Study of Mirdametinib in People With Central Nervous System Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07539441Assessing Brain Metabolism Using MRS With Deuterated Glucose
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06594315Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05489783SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Ap rekriteFaz 1/2
Laj 15 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05588141Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.